Gull Laboratories Toxoplasma gondii test cleared:
This article was originally published in Clinica
Executive Summary
Gull Laboratories' Toxo Igg Elisa test for detecting the protozoan, Toxoplasma gondii, has been cleared by the FDA for marketing in the US. Gull, based in Salt lake City, Utah, estimates that the world market for serological tests for Toxoplasma infection, which can cause a range of birth defects in newborns, to be worth approximately $100 million annually.